Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (11404)	11/18/1997 11:40:00 PM
From: John McCarthy	Read Replies (4) \| Respond to of 32384

Henry - I enjoy reading this thread. It is excellent. I'd like to give the regulars here an insight about the stock price that I am surprized no one talks about. (Warning:To save time, I am going to skip going back and looking at how to spell all these names correctly. Ok?) An average smuck like me, now thinks, that ANY diabetes research is frought with danger. The rationale? Shi* if J&J got blown away .... As such, I will pay attention (as an investor) and think the price will move as follows .... (remember , I don't follow closely and don't know the whole pipeline - only that lgnd is working on diabetes) 1 - If LGND's drug gets thru Phase 3 - there's real price movement 2 - If they get past the Advisory Panel - move 1/3 towards Infinity 3 - If they get past the Final Panel - move 2/3 towards Infinity 4 - If it comes out that their thingie is better than WL's - Skip GO and go directly to Infinity Now my real point here, no matter what the pipeline, Diabetes overshadows all else ..... and therefore .... J&J debacle ..... and therefore ... I'm sure I'm the only one that thinks this way, but you never know ... Regards, John McCarthy